French global pharmaceutical company
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | New buy | 820,078 | $34,984,527 | 0.0% |
| Bridgewater | 56 | New buy | 206,873 | $8,825,202 | 0.0% |
| Louis Bacon / Moore | 53 | Added +24% | 329,779 | $14,068,372 | 0.2% |
| Ancora | 40 | Trimmed -52% | 280 | $11,945 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-03-30 | Alan Armstrong senate | BUY | $15,001 - $50,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.